Teladoc holder Divita files to sell 18,327 shares

A Teladoc Health officer filed a Rule 144 notice to sell 18,327 vested restricted shares, partly to cover tax obligations.

Rhea-AI Filing Summary

Teladoc Health, Inc. (TDOC) is the issuer for which Charles Divita III has filed a notice of proposed sale of restricted shares under Rule 144. The notice covers the potential sale of 18,327 shares of common stock through Fidelity Brokerage Services LLC, with an approximate aggregate market value of $115,483.92 as of September 2, 2026 on the NYSE. The shares to be sold arise from restricted stock vesting on September 1, 2026 and are characterized as compensation from the issuer, with a portion of the sale intended to cover a tax obligation from the vested equity award.

Key Figures

Shares proposed to be sold: 18,327 shares Aggregate market value of proposed sale: $115,483.92 Shares sold on June 2, 2026: 19,132 shares +5 more

8 metrics

Shares proposed to be sold 18,327 shares Common stock covered by the Rule 144 notice for Charles Divita III

Aggregate market value of proposed sale $115,483.92 Estimated value of 18,327 shares as of September 2, 2026

Shares sold on June 2, 2026 19,132 shares Common stock sold in the past 3 months for $145,919.77

Proceeds from June 2, 2026 sale $145,919.77 Value of 19,132 common shares sold

Shares sold on June 11, 2026 18,074 shares Common stock sold in the past 3 months for $125,460.67

Proceeds from June 11, 2026 sale $125,460.67 Value of 18,074 common shares sold

Vesting date of restricted stock September 1, 2026 Date the compensation-related restricted stock vested

Date of Rule 144 notice September 2, 2026 Date the notice of proposed sale was signed and submitted

Key Terms

Rule 144, restricted stock, vested equity award, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock financial

"Common | 09/01/2026 | Restricted Stock Vesting | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

vested equity award financial

"settlement of a vested equity award distribution."

attorney-in-fact regulatory

"as attorney-in-fact for Charles Divita."

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Teladoc Health, Inc. (TDOC)?

It discloses that Charles Divita III has filed to potentially sell 18,327 shares of Teladoc Health common stock under Rule 144 through Fidelity Brokerage Services LLC, based on a market value of $115,483.92 as of September 2, 2026.

Who is selling Teladoc Health (TDOC) shares in this Form 144 notice?

The notice is filed for Charles Divita III, identified in connection with Teladoc Health, Inc. The shares are held and to be sold through Fidelity Brokerage Services LLC acting as broker, with Fidelity signing as attorney-in-fact for Divita.

How many Teladoc Health (TDOC) shares are proposed to be sold and what is their value?

The filing covers a proposed sale of 18,327 shares of Teladoc Health common stock, with an estimated aggregate market value of $115,483.92 as of September 2, 2026, to be sold on the NYSE.

What is the source of the Teladoc Health (TDOC) shares being sold?

The shares come from restricted stock vesting on September 1, 2026, identified as compensation from Teladoc Health, Inc. The remark states that the sale includes an amount needed to cover a tax obligation from settlement of the vested equity award.

What Teladoc Health (TDOC) share sales occurred in the past 3 months for this filer?

In the prior three months, the filer reported selling 19,132 shares of common stock on June 2, 2026 for $145,919.77 and 18,074 shares on June 11, 2026 for $125,460.67.

When is the sale of Teladoc Health (TDOC) shares expected to occur under this notice?

The notice is dated September 2, 2026, and the latest security information reflects that date. The securities to be sold are tied to restricted stock vesting on September 1, 2026, with sales to occur under Rule 144 subject to its conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 03:37 PM EDT Accepted by SEC EDGAR 09/02/2026 - 03:37 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001347535
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Teladoc Health, Inc.
SEC File Number	001-37477
Address of Issuer	155 E 44TH STREET SUITE 1700 NEW YORK NEW YORK 10017
Phone	2036352002
Name of Person for Whose Account the Securities are To Be Sold	DIVITA CHARLES III
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	18327	115483.92	181684021	09/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2026	Restricted Stock Vesting	Issuer			18327	09/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Charles Divita 155 E 44th Street Suite 1700 New York NY 10017	Common	06/02/2026	19132	145919.77
Charles Divita 155 E 44th Street Suite 1700 New York NY 10017	Common	06/11/2026	18074	125460.67

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	09/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Charles Divita.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)